Takeda Pharmaceutical Company Limited ( TAK) - Key Metrics
TAK Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | $754.43 | $65.61 | $220.74 | $194.38 |
| 2025Q2 | $705.43 | -$7.48 | $239.77 | $206.28 |
| 2025Q1 | $707.27 | $79.40 | $130.27 | $99.65 |
| 2024Q4 | $667.36 | -$65.35 | $121.41 | $90.50 |
TAK Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | ? | ? |
| 2025Q3 | 143.80% | 18.42 |
| 2025Q2 | -74.45% | -144.19 |
| 2025Q1 | 116.94% | 13.93 |
| 2024Q4 | -9.44% | -16.88 |
TAK Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q4 | -0.28% | ? |
| 2025Q3 | 4.11% | 1.95% |
| 2025Q2 | 4.77% | 0.13% |
| 2025Q1 | 2.01% | 2.10% |
| 2024Q4 | 2.46% | 0.14% |
TAK
Price: $15.41
Dividend Yield: 4.01%
Forward Dividend Yield: 4.29%
Payout Ratio: 177.09%
Dividend Per Share: 0.62 USD
Earnings Per Share: 0.38 USD
P/E Ratio: 43.63
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Japan
Volume: 2.3 million
Market Capitalization: 48.9 billion
Average Dividend Frequency: 2
Years Paying Dividends: 18
DGR3: 0.19%
DGR5: -4.55%
DGR10: -6.07%